UBS AM’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-203,648
| Closed | -$792K | – | 2726 |
|
|
2024
Q3 | $792K | Sell |
203,648
-27,111
| -12% | -$105K | ﹤0.01% | 2491 |
|
|
2024
Q2 | $905K | Buy |
230,759
+82,801
| +56% | +$325K | ﹤0.01% | 2428 |
|
|
2024
Q1 | $620K | Hold |
147,958
| – | – | ﹤0.01% | 2219 |
|
|
2023
Q4 | $695K | Hold |
147,958
| – | – | ﹤0.01% | 2209 |
|
|
2023
Q3 | $462K | Buy |
147,958
+85,745
| +138% | +$268K | ﹤0.01% | 2326 |
|
|
2023
Q2 | $308K | Hold |
62,213
| – | – | ﹤0.01% | 2471 |
|
|
2023
Q1 | $308K | Sell |
62,213
-687
| -1% | -$3.4K | ﹤0.01% | 2471 |
|
|
2022
Q4 | $343K | Hold |
62,900
| – | – | ﹤0.01% | 2304 |
|
|
2022
Q3 | $409K | Hold |
62,900
| – | – | ﹤0.01% | 2416 |
|
|
2022
Q2 | $298K | Buy |
62,900
+16,900
| +37% | +$79.9K | ﹤0.01% | 2481 |
|
|
2022
Q1 | $322K | Hold |
46,000
| – | – | ﹤0.01% | 2580 |
|
|
2021
Q4 | $469K | Buy |
+46,000
| New | +$469K | ﹤0.01% | 2586 |
|